Cara Therapeutics | CARA - Acreedores Comerciales

Precio De Mercado
2.90
Cambio Diario
-0.06 -2.03%
Mensual
-23.28%
Anual
-80.27%
Q2 Expectativa
2.82




Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Assertio Holdings USD 14.66M 3.81M 2025-09
Cara Therapeutics USD 4.08M 1.65M 2025-09
Cassava Sciences USD 41.65M 4.44M 2025-12
Chugai Pharma JPY 127.25B 48.35B 2025-12
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
J&J USD 11.99B 2.37B 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pacira USD 15.15M 2.54M 2025-12
Pfizer USD 5.02B 142M 2025-09
RedHill Biopharma USD 835K 7.03M 2025-06
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12